Reason for request
Extension of indication
Clinical Benefit
| Substantial |
The actual benefit of BERINERT is substantial in th is extension of the indication to the short-term pre-procedure prevention of acute HAE episodes. |
Clinical Added Value
| no clinical added value |
For the short-term pre-procedure prevention of acute HAE episodes, BERINERT does not provide any improvement in actual benefit (IAB V, non-existent) over other treatments already available. |
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
J6nMMFZhp7NUtma5
